The global radiopharmaceuticals market is entering a dynamic growth phase, propelled by advancements in nuclear medicine and the increasing demand for targeted diagnostics and therapies. Valued at US$ 6.6 billion in 2024, the industry is projected to grow at a CAGR of 7.6% from 2025 to 2035, reaching US$ 14.6 billion by 2035. The expanding role of radiopharmaceuticals in oncology, cardiology,...